Severe ulcerative colitis: At what point should we define resistance to steroids?

World Journal of Gastroenterology

Volumn 14, Issue 36, 2008, Pages 5504-5507

  Esteve, Maria ^a   Gisbert, Javier P ^b,c  

^a HOSPITAL MÚTUA DE TERRASSA   (Spain)

^b HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Resistance; Severe; Steroids; Ulcerative colitis

Indexed keywords

CORTICOSTEROID; DEXAMETHASONE; HYDROCORTISONE; INFLIXIMAB; METHYLPREDNISOLONE; PREDNISOLONE; PREDNISONE; ANTIINFLAMMATORY AGENT; GASTROINTESTINAL AGENT;

ARTICLE; COLON RESECTION; DISEASE SEVERITY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DOSAGE FORM COMPARISON; DRUG DOSE COMPARISON; DRUG EFFICACY; HUMAN; MEDICAL DECISION MAKING; MORTALITY; PATIENT COMPLIANCE; REMISSION; TREATMENT DURATION; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT RESPONSE; ULCERATIVE COLITIS; DOSE RESPONSE; DRUG ADMINISTRATION ROUTE; DRUG RESISTANCE; HOSPITALIZATION; NOMENCLATURE; PATIENT SELECTION; REVIEW; TIME;

ADRENAL CORTEX HORMONES; ANTI-INFLAMMATORY AGENTS; COLECTOMY; COLITIS, ULCERATIVE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION ROUTES; DRUG RESISTANCE; GASTROINTESTINAL AGENTS; HUMANS; PATIENT SELECTION; SEVERITY OF ILLNESS INDEX; TERMINOLOGY AS TOPIC; TIME FACTORS; TREATMENT FAILURE;

EID: 58149183264     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.14.5504     Document Type: Article

References (24)

1. Hardy TL, Bulmer E. Ulcerative colitis. Br Med J 1933; 2: 812-815
2. Turner D, Walsh CM, Steinhart AH, Griffiths AM. Response to corticosteroids in severe ulcerative colitis: a systematic review of the literature and a meta-regression. Clin Gastroenterol Hepatol 2007; 5: 103-110
3. Truelove SC, Witts LJ. Cortisone in ulcerative colitis; preliminary report on a therapeutic trial. Br Med J 1954; 2: 375-378
4. Truelove SC, Willoughby CP, Lee EG, Kettlewell MG. Further experience in the treatment of severe attacks of ulcerative colitis. Lancet 1978; 2: 1086-1088
5. Baron JH, Connell AM, Kanaghinis TG, Lenneard-Jones JE, Jones AF. Out-patient treatment of ulcerative colitis. Comparison between three doses of oral prednisone. Br Med J 1962; 2: 441-443
6. Sood A, Midha V, Sood N, Awasthi G. A prospective, open-label trial assessing dexamethasone pulse therapy in moderate to severe ulcerative colitis. J Clin Gastroenterol 2002; 35: 328-331
7. Elliott PR, Powell-Tuck J, Gillespie PE, Laidlow JM, Lennard-Jones JE, English J, Chakraborty J, Marks V. Prednisolone absorption in acute colitis. Gut 1980; 21: 49-51
8. Berghouse LM, Elliott PR, Lennard-Jones JE, English J, Marks V. Plasma prednisolone levels during intravenous therapy in acute colitis. Gut 1982; 23: 980-983
9. Seo M, Okada M, Yao T, Ueki M, Arima S, Okumura M. An index of disease activity in patients with ulcerative colitis. Am J Gastroenterol 1992; 87: 971-976
10. Travis SP. Predicting outcome in severe ulcerative colitis. Dig Liver Dis 2004; 36: 448-449
11. Travis S. Review article: saving the colon in severe colitis - the case for medical therapy. Aliment Pharmacol Ther 2006; 24 Suppl 3: 68-73
12. Stenner JMC, White P, Gould SR, Lim AG. Audit of the management of severe ulcerative colitis in a DGH. Gut 2001; 48 Suppl 1: A87
13. Dolwani S, Hawthorne AB. Mortality caused by inflammatory bowel disease in the UK: a two year survey. Gut 2003; 52 Suppl 1: A12
14. Hawthorne AB, Travis SP. Outcome of inpatient management of severe ulcerative colitis: a BSG IBD clinical trials network survey. Gut 2002; 50: A16
15. Meyers S, Lerer PK, Feuer EJ, Johnson JW, Janowitz HD. Predicting the outcome of corticoid therapy for acute ulcerative colitis. Results of a prospective, randomized, double-blind clinical trial. J Clin Gastroenterol 1987; 9: 50-54
16. Daperno M, Sostegni R, Scaglione N, Ercole E, Rigazio C, Rocca R, Pera A. Outcome of a conservative approach in severe ulcerative colitis. Dig Liver Dis 2004; 36: 21-28
17. Gold DM, Levine JJ, Weinstein TA, Kessler B, Pettei MJ. Prolonged medical therapy for severe pediatric ulcerative colitis. Am J Gastroenterol 1995; 90: 732-735
18. Carbonnel F, Boruchowicz A, Duclos B, Soule JC, Lerebours E, Lemann M, Belaiche J, Colombel JF, Cosnes J, Gendre JP. Intravenous cyclosporine in attacks of ulcerative colitis: short-term and long-term responses. Dig Dis Sci 1996; 41: 2471-2476
19. Travis SP, Farrant JM, Ricketts C, Nolan DJ, Mortensen NM, Kettlewell MG, Jewell DP. Predicting outcome in severe ulcerative colitis. Gut 1996; 38: 905-910
20. Mañosa M, Doménech E, Gordillo J, Esteve M, García-Planella E, Cabré E, Bernal I, Zabana Y, Gassull MA. Prospective study of early predictors of response to corticosteroids (CS) in moderate to severe acute flares of ulcerative colitis (UC) and validation in an independent cohort. Gut 2007; 56 suppl: A155
21. Lindgren SC, Flood LM, Kilander AF, Lofberg R, Persson TB, Sjodahl RI. Early predictors of glucocorticosteroid treatment failure in severe and moderately severe attacks of ulcerative colitis. Eur J Gastroenterol Hepatol 1998; 10: 831-835
22. Ho GT, Mowat C, Goddard CJ, Fennell JM, Shah NB, Prescott RJ, Satsangi J. Predicting the outcome of severe ulcerative colitis: development of a novel risk score to aid early selection of patients for second-line medical therapy or surgery. Aliment Pharmacol Ther 2004; 19: 1079-1087
23. Silverberg MS, Satsangi J, Ahmad T, Arnott ID, Bernstein CN, Brant SR, Caprilli R, Colombel JF, Gasche C, Geboes K, Jewell DP, Karban A, Loftus Jr EV, Pena AS, Riddell RH, Sachar DB, Schreiber S, Steinhart AH, Targan SR, Vermeire S, Warren BF. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005; 19 Suppl A: 5-36
24. Järnerot G, Hertervig E, Friis-Liby I, Blomquist L, Karlén P, Grännö C, Vilien M, Ström M, Danielsson A, Verbaan H, Hellström PM, Magnuson A, Curman B. Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study. Gastroenterology 2005; 128: 1805-1811